INS and Hyperkalemia: Furthermore, established treatments for acute hyperkalaemia—such as insulin–dextrose infusions—have been shown to be associated with significant morbidity, particularly with repeated doses in which iatrogenic hypoglycaemia is associated with increased rates of death [27, 28].